Noteworthy Tuesday Option Activity: SCHW, GPN, WGS

Significant options flow was observed in Global Payments (GPN) and GeneDx Holdings (WGS) today: GPN saw 16,123 contracts traded (≈1.6M underlying shares), about 53% of its one‑month average daily volume, led by 7,070 contracts in the $60 put expiring Feb. 20, 2026 (≈707,000 shares). WGS saw 2,883 contracts (≈288,300 shares), about 52% of its one‑month average, with 1,512 contracts in the $150 call expiring Apr. 17, 2026 (≈151,200 shares); these concentrated flows may signal elevated speculative positioning and potential short‑term volatility or liquidity effects in the two names.

Analysis

Market structure: Large Feb‑2026 $60 put flow in GPN (~707k shares, ~53% ADTV) signals concentrated demand for downside protection or a directional bearish bet; dealers will delta‑hedge by selling stock into weakness which can amplify moves near catalyst dates. WGS call flow (Apr‑2026 $150, ~151k shares, ~52% ADTV) implies idiosyncratic upside expectations (M&A, regulatory win, or positive guidance) and will force dealers to buy stock on rallies, compressing available sell pressure in a small‑cap name.

Risk assessment: Immediate (days) risk is elevated IV and dealer hedging creating transient price moves; short‑term (weeks–months) risk centers on earnings, FDA/CLIA/M&A headlines for WGS and merchant pricing/regulatory scrutiny for GPN. Tail scenarios: regulatory clampdown on interchange or a major data breach for GPN; for WGS, failed clinical/validation data or a botched M&A process could gap stock down >30%. Hidden dependency: the block trades may be synthetic spreads or collateral for other portfolio exposures — options flow alone can mislead about directional intent.

Trade implications: For GPN prefer defined‑risk bearish structures (Feb‑26 put debit spreads) or selling short dated covered calls if long equity — avoid naked short puts. For WGS, favored is a directional call spread into Apr‑26 to capture potential M&A/clinical upside while capping premium; isolate market beta by pairing with a short SPY or IBB sized to match delta. Monitor IV crush and set strict delta/IV thresholds: enter when IV is within 10% of 30‑day median and exit on 20–30% P/L or on catalyst resolution.

Contrarian angle: Consensus treats large option volume as pure directional signal but >50% ADTV blocks are often hedges — if GPN’s put buyers are hedgers, downside may be limited and vol may collapse, making bought puts expensive. Historically, heavy single‑strike flows can precede mean‑reversion once catalysts pass (lookback: post‑block trades in small caps show 7–21 day reversals ~10–15%). Unintended consequence: dealer hedging can create short squeezes if moves reverse, so manage exposure with spreads and tight stops.

Key Decisions for Investors

• Establish a defined‑risk bearish position in GPN: buy Feb‑20‑2026 $60/$55 put debit spread sized 1.0–2.0% of portfolio notional to capture downside to $55 while capping premium; close if GPN trades >$65 for three consecutive sessions or if spread gains 30%+.
• Establish a directional bullish position in WGS: buy Apr‑17‑2026 $150/$170 call vertical (or long $150 call if willing to pay premium) sized 0.5–1.0% of portfolio; hedge market beta by shorting SPY delta‑equivalent to the trade and take profits at +40% or if WGS >$180 prior to expiry.
• If already long GPN equity, hedge with Feb‑2026 $60 puts (buy) sized to cover 50–100% of position rather than selling into volatility; remove hedge if put implied volatility falls >25% from current level or after next earnings cycle (~60 days).